Several tech startups — ClickHouse, Furl, PraxisPro, among others, have announced their venture capital funding to bolster innovation and business growth.
ClickHouse Raises $400 mn
ClickHouse announced a $400 million Series D financing led by Dragoneer Investment Group with participation from Bessemer Venture Partners, GIC, Index Ventures, Khosla Ventures, Lightspeed Venture Partners, accounts advised by T. Rowe Price Associates, Inc., and WCM Investment Management to accelerate expansion in analytics and AI infrastructure. The funding will support unified transactional and analytical workloads, LLM observability with the acquisition of Langfuse, and global growth of ClickHouse Cloud. CEO Aaron Katz highlighted the strategy to deliver high-performance real-time data processing for AI systems while improving developer experiences and customer outcomes. The technology focus includes expanded Postgres integration and deeper global partnerships to drive innovation and scalability.
Furl Raises $10 mn
Furl secured $10 million in a Seed funding round led by Ten Eleven Ventures, with participation from Rapid7 CEO Corey Thomas and Open Opportunity Fund to advance agentic AI for security remediation. Founded by cybersecurity veterans, the company aims to automate execution of fixes rather than just detecting vulnerabilities. Furl’s platform ingests findings from existing security tools and uses autonomous AI to perform context-aware remediation, reducing backlogs and operational burden for enterprise security teams. CEO Derek Abdine emphasized that closing the execution gap enhances IT security resilience. The investment will accelerate product development, expand operating system coverage, and deepen autonomous remediation capabilities, delivering faster risk reduction and improved operational productivity.
PraxisPro Raises $6 mn
PraxisPro closed a $6 million Seed round led by AlleyCorp with participation from Flybridge, South Loop Ventures, Zeal Capital Partners, True Ventures, Techstars, Alumni Ventures, and Daring Ventures to transform life sciences commercial intelligence using AI. The company is leveraging small language models and AI agents to unify fragmented data, enhance training, and support actionable insights for commercial, medical, and compliance teams. Founder and CEO Cam Badger highlighted the platform’s ability to generate disciplined, governed data to improve patient outcomes and drive performance execution. The strategy includes enhancing therapeutic and disease state models, improving mobile and self-service experiences, and expanding the team to support customers across the life sciences domain.
THASNIYA VP
